{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:56Z","timestamp":1793134136391,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22240-2","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T01:36:23Z","timestamp":1742348183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Global, regional, and national multiple myeloma burden from 1990 to 2021: a systematic analysis for of the Global Burden of Disease Study 2021"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiuxue","family":"Diao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianru","family":"Ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"2","key":"22240_CR1","doi-asserted-by":"publisher","first-page":"101168","DOI":"10.1016\/j.blre.2024.101168","volume":"64","author":"SE Clarke","year":"2024","unstructured":"Clarke SE, Fuller KA, Erber WN. Chromosomal defects in multiple myeloma. Blood Rev. 2024;64(2):101168\u2013101168. https:\/\/doi.org\/10.1016\/j.blre.2024.101168.","journal-title":"Blood Rev"},{"key":"22240_CR2","doi-asserted-by":"publisher","unstructured":".Florent Malard, Neri P, Bahlis NJ, et al. Multiple myeloma. Nat Rev Dis Primers. 2024;10(1). https:\/\/doi.org\/10.1038\/s41572-024-00529-7","DOI":"10.1038\/s41572-024-00529-7"},{"key":"22240_CR3","doi-asserted-by":"publisher","unstructured":".Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk\u2010stratification, and management. Am J Hematol. 2024;99(9). https:\/\/doi.org\/10.1002\/ajh.27422","DOI":"10.1002\/ajh.27422"},{"key":"22240_CR4","doi-asserted-by":"publisher","unstructured":".Rajkumar SV. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91(7):719\u2013734. https:\/\/doi.org\/10.1002\/ajh.24402","DOI":"10.1002\/ajh.24402"},{"issue":"S1","key":"22240_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hon.2586","volume":"37","author":"SV Rajkumar","year":"2019","unstructured":"Rajkumar SV. Multiple myeloma: Every year a new standard? Hematol Oncol. 2019;37(S1):62\u20135. https:\/\/doi.org\/10.1002\/hon.2586.","journal-title":"Hematol Oncol"},{"issue":"9","key":"22240_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","volume":"4","author":"AJ Cowan","year":"2018","unstructured":"Cowan AJ, Allen C, Barac A, et al. Global Burden of Multiple Myeloma. JAMA Oncol. 2018;4(9):1221. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2128.","journal-title":"JAMA Oncol"},{"issue":"4","key":"22240_CR7","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1172\/jci129205","volume":"130","author":"SA Minnie","year":"2020","unstructured":"Minnie SA, Hill GR. Immunotherapy of multiple myeloma. J Clin Invest. 2020;130(4):1565\u201375. https:\/\/doi.org\/10.1172\/jci129205.","journal-title":"J Clin Invest"},{"issue":"4","key":"22240_CR8","doi-asserted-by":"publisher","first-page":"217440","DOI":"10.1016\/j.canlet.2025.217440","volume":"611","author":"X Dou","year":"2025","unstructured":"Dou X, Duan G, Zhong Y, et al. The Burden of Multiple Myeloma in China: Trends from 1990 to 2021 and Forecasts for 2050. Cancer Lett. 2025;611(4):217440\u2013217440. https:\/\/doi.org\/10.1016\/j.canlet.2025.217440.","journal-title":"Cancer Lett"},{"key":"22240_CR9","doi-asserted-by":"publisher","unstructured":".Rajkumar SV. Value and Cost of Myeloma Therapy. Am Soc Clin Oncol Educ Book. 2018;38:662\u2013666. https:\/\/doi.org\/10.1200\/edbk_200867.","DOI":"10.1200\/edbk_200867"},{"key":"22240_CR10","doi-asserted-by":"publisher","unstructured":"Deng W, Zhao L, Chen C, et al. National burden and risk factors of diabetes mellitus in China from 1990 to 2021: Results from the Global Burden of Disease study 2021. J Diabetes. 2024;16(10). https:\/\/doi.org\/10.1111\/1753-0407.70012.","DOI":"10.1111\/1753-0407.70012"},{"key":"22240_CR11","doi-asserted-by":"publisher","unstructured":"Zhang C, Liu W, Wang L, et al. Prevalence and Burden of Multiple Sclerosis in China, 1990\u20132019. Neurology. 2024;102(11). https:\/\/doi.org\/10.1212\/wnl.0000000000209351.","DOI":"10.1212\/wnl.0000000000209351"},{"issue":"20","key":"22240_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.scitotenv.2015.05.017","volume":"530\u2013531","author":"Y Kobayashi","year":"2015","unstructured":"Kobayashi Y, Peters G, Ashbolt NJ, Shiels S, Khan SJ. Assessing burden of disease as disability adjusted life years in life cycle assessment. Sci Total Environ. 2015;530\u2013531(20):120\u20138. https:\/\/doi.org\/10.1016\/j.scitotenv.2015.05.017.","journal-title":"Sci Total Environ"},{"key":"22240_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fpubh.2022.938770","volume":"2022","author":"Y Zhao","year":"1990","unstructured":"Zhao Y, Niu D, Ye E, Trends S, in the Burden of Multiple Myeloma From, et al. to 2019 and Its Projection Until 2044 in China. Front Public Health. 1990;2022:10. https:\/\/doi.org\/10.3389\/fpubh.2022.938770.","journal-title":"Front Public Health"},{"issue":"5","key":"22240_CR14","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1182\/blood-2007-08-104984","volume":"111","author":"H Brenner","year":"2008","unstructured":"Brenner H, Gondos A, Pulte D. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood. 2008;111(5):2521\u20136. https:\/\/doi.org\/10.1182\/blood-2007-08-104984.","journal-title":"Blood"},{"issue":"7","key":"22240_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1200\/JCO.18.00685","volume":"37","author":"EA Stadtmauer","year":"2019","unstructured":"Stadtmauer EA, Pasquini MC, Blackwell B, et al. Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial. J Clin Oncol. 2019;37(7):589\u201397. https:\/\/doi.org\/10.1200\/JCO.18.00685.","journal-title":"J Clin Oncol"},{"issue":"5","key":"22240_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1158\/2643-3230.bcd-21-0028","volume":"2","author":"G Lancman","year":"2021","unstructured":"Lancman G, Sastow DL, Cho HJ, et al. Bispecific Antibodies in Multiple Myeloma: Present and Future. Blood Can Dis. 2021;2(5):423\u201333. https:\/\/doi.org\/10.1158\/2643-3230.bcd-21-0028.","journal-title":"Blood Can Dis"},{"key":"22240_CR17","doi-asserted-by":"publisher","unstructured":"Boussi L, Avigan ZM, Rosenblatt J. Immunotherapy for the treatment of multiple myeloma. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1027385.","DOI":"10.3389\/fimmu.2022.1027385"},{"key":"22240_CR18","doi-asserted-by":"publisher","unstructured":"Rafae A, Frits van Rhee, Samer Al Hadidi. Perspectives on the Treatment of Multiple Myeloma. PubMed. 2023;29(3). https:\/\/doi.org\/10.1093\/oncolo\/oyad306.","DOI":"10.1093\/oncolo\/oyad306"},{"key":"22240_CR19","doi-asserted-by":"publisher","unstructured":"Holstein S. Current Frontline Treatment of Multiple Myeloma. ONCOLOGY. 2022;36(07). https:\/\/doi.org\/10.46883\/2022.25920967","DOI":"10.46883\/2022.25920967"},{"key":"22240_CR20","doi-asserted-by":"publisher","unstructured":"Derman BA, Langerman SS, Maric M, Jakubowiak A, Zhang W, Chiu BC \u2010H. Sex differences in outcomes in multiple myeloma. Br J Haematol. 2020;192(3). https:\/\/doi.org\/10.1111\/bjh.17237.","DOI":"10.1111\/bjh.17237"},{"issue":"1","key":"22240_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/medsci9010003","volume":"9","author":"SA Padala","year":"2021","unstructured":"Padala SA, Barsouk A, Barsouk A, et al. Epidemiology, Staging, and Management of Multiple Myeloma. Med Sci. 2021;9(1):3. https:\/\/doi.org\/10.3390\/medsci9010003.","journal-title":"Med Sci"},{"key":"22240_CR22","doi-asserted-by":"publisher","unstructured":"Chattopadhyay S, Yu H, Sud A, et al. Multiple myeloma: family history and mortality in second primary cancers. Blood Can J. 2018;8(8). https:\/\/doi.org\/10.1038\/s41408-018-0108-15.","DOI":"10.1038\/s41408-018-0108-15"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22240-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22240-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22240-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T01:36:25Z","timestamp":1742348185000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22240-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22240"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22240-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1054"}}